Last reviewed · How we verify
NCT04567823: NovAL
Nutrient Bioavailability From Microalgae
NA trial testing Smoothie with microalgae in Nutrient Deficiency in 80 participants. Completed in 31 December 2020.
12 December 2020
Quick facts
| Lead sponsor | University of Jena |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | prevention |
| Enrollment | 80 |
| Start date | 9 November 2020 |
| Primary completion | 12 December 2020 |
| Estimated completion | 31 December 2020 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Smoothie with microalgae
Conditions studied
- Nutrient Deficiency — all drugs for Nutrient Deficiency →
Sponsor
University of Jena
Who can join
Adults 20 to 35, any sex, with Nutrient Deficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The intervention study is designed to evaluate nutrient bioavailability and physiological impact of two selected microalgae species of interest in a randomized study in humans. The controlled study in parallel design will be conducted with healthy males and females between 20 and 35 years.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Impact of Regular Intake of Microalgae on Nutrient Supply and Cardiovascular Risk Factors: Results from the NovAL Intervention Study.
Sandgruber F, Höger AL, Kunze J, Schenz B, et al · · 2023 · cited 8× · PMID 37049486 · DOI 10.3390/nu15071645 -
Algae-Derived Bioactive Compounds as Platforms for Translational Biotechnology and Health Applications.
Morris H, Coombes Z, El Dor Z, Rodrigues VJ, et al · · 2026 · PMID 42200944 · DOI 10.3390/biotech15020034
Verify or expand the search:
- PubMed search for NCT04567823
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Nutrient Deficiency
Currently open trials in the same condition.
- NCT07271316 — Alii Supplement Study · Phase 2 · recruiting
- NCT06835738 — Implementation of Multiple Micronutrient Supplementation (MMS) for Pregnant Women in Uganda · NA · recruiting
- NCT05608772 — Conversion to SADI-S, RYGB or OAGB After Failed Sleeve · NA · recruiting
- NCT06025786 — Impact Evaluation of Benazir Nashonuma Program (BNP) on Stunting Among Under-five Children · NA · recruiting
- NCT04288531 — Iodine Impact on Thyroid Function and Psychomotor Development, Observational Study in the Portuguese Minho Region · active not recruiting
Other University of Jena trials
Trials by the same sponsor.
- NCT07189481 — Design and Evaluation of a Team Timeout Checklist (TTOC) to Improve Information Exchange in the Operating Room Before Sk · completed
- NCT05814874 — Improvement of the Selenium Supply in a Vegan Diet by Different Selenium Sources · NA · completed
- NCT05382533 — MoKaRi II Intervention Study · NA · completed
- NCT05067465 — Nutritional Biomarker Screening for Defined Food Groups · NA · completed
- NCT04902937 — Association of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04567823 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Jena
- Last refreshed: 13 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04567823.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing